ID

35104

Descripción

LIquid BIopsies in Lung Cancer (LIBIL); ODM derived from: https://clinicaltrials.gov/show/NCT02511288

Link

https://clinicaltrials.gov/show/NCT02511288

Palabras clave

Versiones (1)
  1. 17/2/19 17/2/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

17 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

Inglés

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

1 formularios  
Criteria
Descripción

Criteria

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
Descripción

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C0332291
UMLS CUI [2,2]
C0026882
UMLS CUI [2,3]
C0449438
inclusion at the time of diagnostic or at relapse
Descripción

Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C0277556
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
Descripción

Neoplasm Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0005558
age ≥ 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated before their liquid biopsy
Descripción

Therapeutic procedure Before Liquid Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4505151
cohort 2 inclusion criteria
Descripción

Cohort Number | Inclusion criteria

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0599755
UMLS CUI [1,2]
C0237753
UMLS CUI [2]
C1512693
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
Descripción

Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C3258246
UMLS CUI [2,1]
C1704257
UMLS CUI [2,2]
C1265611
UMLS CUI [3]
C3266992
UMLS CUI [4]
C1511021
UMLS CUI [5]
C3273087
UMLS CUI [6]
C4329227
UMLS CUI [7]
C4331215
UMLS CUI [8]
C1711106
inclusion at the time of diagnostic or at relapse
Descripción

Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348792
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C2348792
UMLS CUI [2,3]
C0277556
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
Descripción

Neoplasm Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0005558
age ≥ 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients treated before their liquid biopsy
Descripción

Therapeutic procedure Before Liquid Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C4505151
Volver a la parte superior de la página

Similar models

Eligibility Carcinoma, Non-small Cell Lung NCT02511288

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Independent of Mutation Status
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) regardless of the mutation status
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C0332291 (UMLS CUI [2,1])
C0026882 (UMLS CUI [2,2])
C0449438 (UMLS CUI [2,3])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Cohort Number | Inclusion criteria
Item
cohort 2 inclusion criteria
boolean
C0599755 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
C1512693 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma Advanced TNM clinical staging | Molecular Abnormality Quantity | EGFR gene mutation | BRAF gene mutation | HER2 Gene Mutation | ALK Gene Translocation | ROS1 Gene Translocation | MET Gene Amplification
Item
patients with histologically confirmed advanced non-small-cell lung carcinoma (stage iiib/iv) with one of the following molecular anomalies: epidermal growth factor receptor (egfr), b-raf proto oncogene (braf) or human epidermal growth factor receptor-2 (her2) mutations, anaplatsic lymphoma kinase (alk) or ros porto-oncogene 1 (ros1) translocation, mesenchymal-epithelial transition factor (met) amplification.
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C1704257 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C3266992 (UMLS CUI [3])
C1511021 (UMLS CUI [4])
C3273087 (UMLS CUI [5])
C4329227 (UMLS CUI [6])
C4331215 (UMLS CUI [7])
C1711106 (UMLS CUI [8])
Inclusion Timepoint Diagnosis | Inclusion Timepoint Recurrent disease
Item
inclusion at the time of diagnostic or at relapse
boolean
C1512693 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C2348792 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
Neoplasm Biopsy
Item
realization of tumor biopsy at the institution (centre léon bérard) or outside the institution with an available histopathological report
boolean
C0027651 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic procedure Before Liquid Biopsy
Item
patients treated before their liquid biopsy
boolean
C0087111 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C4505151 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial